Summary of clinical studies with vaginal formulations of terconazole.
D000935:Antifungal Agents / Q000008:administration & dosage*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D013488:Suppositories; D014230:Triazoles / Q000008:administration & dosage*; D014622:Vaginal Creams, Foams, and Jellies
D000935:Antifungal Agents; D013488:Suppositories; D014230:Triazoles; D014622:Vaginal Creams, Foams, and Jellies; C037815:terconazole